Vancouver, Canada – February 3, 2025 – Augurex is excited to announce that it will attend the RheumNow Live 2025 conference, a premier event bringing together leading rheumatologists and researchers to discuss the latest advancements in rheumatic disease diagnostics, treatments, and patient care.
Rheumatic diseases, including rheumatoid arthritis (RA) and axial spondyloarthritis (axSpA), require early and accurate diagnosis to improve patient outcomes. This conference is a key platform for discussing innovative approaches in rheumatology, from emerging therapies to biomarker-driven diagnostics that support precision medicine.
At Augurex, we are committed to advancing biomarker-driven solutions, including the 14-3-3eta biomarker for RA and the Anti-14-3-3eta Multiplex biomarker for axSpA, to support earlier detection and more precise treatment strategies.
If you’re attending RheumNow Live 2025, let’s connect to discuss how biomarker research is improving disease management in rheumatology. Stay tuned for updates from the event.
Learn more about the conference here:
Event Details & Registration
About Augurex
Augurex is a commercial stage diagnostics company dedicated to the early identification and diagnosis of autoimmune disorders, allowing treatment options to be optimized and personalized for patients around the world. Augurex’s lead diagnostic test which detects the 14-3-3eta protein, available as JOINTstat® in Canada, is an important tool in the diagnosis and management of inflammatory diseases, including rheumatoid arthritis. The analyte specific reagents to detect 14-3-3eta are available for purchase and use by U.S. clinical laboratories as a component of diagnostic tests developed by such laboratories. The Anti-14-3-3eta Multiplex ASRs expand Augurex’s biomarker-informed diagnostic autoimmune solutions into axial spondyloarthritis, an autoimmune disease often misdiagnosed as low back pain, and which if untreated can lead to impaired spinal mobility and fusion of the vertebrae. Learn more about Augurex at www.augurex.com and follow us on Facebook, LinkedIn and X.
Media Contact
Nima Mazinani
(604) 674-8231
[email protected]